RELY - ABLE (Ongoing)
Long Term Multi-Center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed the RE-LY Trial and a Cluster Randomised Trial to Assess the Effect of a Knowledge Translation Intervention on Patient Outcomes.
|
< back
|
 The purposes of this study is to evaluate the long-term safety of dabigatran etexilate and to assess the effect of a knowledge translation intervention on patient outcomes
Study Design: Treatment, Parallel assignment, Safety study
Intervention: Two blinded doses of Dabigatran etexilate
Length of Study: 28 months
# of Patients: 6,000
Patient Populations: Atrial fibrillation
Presentations
Available upon study completion.
Main Publications (for a full listing of publications, please visit the 'Media and Publications' section)
|
Not available at this time.
|
| 
